Open-label Study on Small Bowel Lesions Suggestive of Crohn's Disease in Patients With Moderate to Severe Plaque Psoriasis Treated With Adalimumab
Phase of Trial: Phase IV
Latest Information Update: 04 Jul 2016
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease; Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Innovaderm Research
- 10 Jun 2017 Biomarkers information updated
- 28 Jun 2016 Status changed from active, no longer recruiting to completed.
- 22 Feb 2016 Planned End Date changed from 1 Dec 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov.